CA19-9 Antibody

SKU: orb750179

Description

CA19-9, a carbohydrate epitope expressed on a high MW (>400kDa) mucin glycoprotein, is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group antigens.

Images & Validation

• Tested Applications: IHC-P
• Dilution range: Immunohistochemistry (FFPE): 5-10ug/ml for 30 min at RT
• Reactivity: Human
• Application Notes:
  Optimal dilution of the recombinant CA19-9 antibody should be determined by the researcher.1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.

Key Properties

• Antibody Type: Primary Antibody
• Host: Rabbit
• Clonality: Recombinant
• Isotype: Rabbit IgG, kappa
• Clone No.: CA19.9/1390R
• Immunogen: Purified human protein used as the immunogen for the recombinant CA19-9 antibody.
• Conjugation: Unconjugated

Storage & Handling

• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Disclaimer: For research use only

IHC testing of FFPE human gastric carcinoma with recombinant CA19-9 antibody (clone CA19.9/1390R). HIER: steam sections in pH6 citrate buffer for 10-20 min.

SDS-PAGE Analysis of Purified, BSA-Free Recombinant CA19-9 Antibody (clone CA19.9/1390R). Confirmation of Integrity and Purity of the Antibody.

Quick Database Links

UniProt

Not Known